Stay updated with breaking news from Nasdaq Crmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CorMedix Inc. (NASDAQ:CRMD – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 9,380,000 shares, an increase of 13.7% from the March 31st total of 8,250,000 shares. Based on an average daily volume of 587,000 shares, the […]
SG Americas Securities LLC bought a new stake in CorMedix Inc. (NASDAQ:CRMD – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 28,465 shares of the company’s stock, valued at approximately $107,000. Several other institutional investors also recently […]
CorMedix (NASDAQ:CRMD – Free Report) had its price target trimmed by Truist Financial from $18.00 to $14.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other analysts have also recently issued reports on CRMD. Needham & Company LLC reduced their price objective on CorMedix […]
Wick Capital Partners LLC cut its stake in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) by 55.4% during the second quarter, Holdings Channel reports. The firm owned 24,450 shares of the company’s stock after selling 30,400 shares during the quarter. Wick Capital Partners LLC’s holdings in CorMedix were worth $97,000 at the end of […]
Truist Financial restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a report published on Wednesday morning, Benzinga reports. The firm currently has a $18.00 price objective on the stock. Several other research firms also recently weighed in on CRMD. Royal Bank of Canada upped their price objective on shares of […]